Improving pneumococcal and herpes zoster vaccination uptake: Expanding pharmacist privileges

American Journal of Managed Care

Volumn 19, Issue 9, 2013, Pages

  Taitel, Michael S ^a   Fensterheim, Leonard E ^a   Cannon, Adam E ^a   Cohen, Edward S ^a  

^a Walgreen   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; VARICELLA ZOSTER VACCINE;

ARTICLE; BILLING AND CLAIMS; HERPES ZOSTER; HIGH RISK PATIENT; HUMAN; INFECTION PREVENTION; INFLUENZA VACCINATION; PATIENT SELECTION; PHARMACIST; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; VACCINATION; CROSS-SECTIONAL STUDY; FEMALE; GOVERNMENT; LEGISLATION AND JURISPRUDENCE; MALE; MIDDLE AGED; PHARMACY; PROFESSIONAL STANDARD; UNITED STATES; UTILIZATION;

COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; FEMALE; HERPES ZOSTER VACCINE; HUMANS; MALE; MIDDLE AGED; PHARMACISTS; PNEUMOCOCCAL VACCINES; PROFESSIONAL ROLE; STATE GOVERNMENT; UNITED STATES; VACCINATION;

EID: 84883758515     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Rambhia KJ, Watson M, Sell TK, Waldhorn R, Toner E. Mass vaccination for the 2009 H1N1 pandemic: approaches, challenges, and recommendations. Biosecur Bioterror. 2010;8(4):321-330.
2. Crawford ND, Blaney S, Amesty S, et al. Individual-and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists' role in reducing racial/ethnic disparities in influenza vaccinations in New York City. J Urban Health. 2011;88(1):176-185.
3. CDC. Adult vaccination coverage-United States, 2010. MMWR. 2012; 61(4):66-72.
4. Uscher-Pines L, Maurer J, Kellerman A, Harris KM. Healthy young and middle age adults: what will it take to vaccinate them for influenza? Vaccine. 2010;28(46):7420-7422.
5. Westrick SC. Pharmacy characteristics, vaccination service characteristics, and service expansion: an analysis of sustainers and new adopters. J Am Pharm Assoc. 2010;50(1):52-61.
6. Francis MAH. Vaccination services through community pharmacy: a literature review. Public Health Wales; August 17, 2010.
7. American Pharmacists Association and Academy of Managed Care Pharmacy. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting. J Am Pharm Assoc. 2011;51(6):704-712.
8. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1997;46(RR-8):1-24.
9. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2008;57(RR-5):1-30; quiz CE32-34.
10. Taitel M, Cohen E, Duncan I, Pegus C. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations [published online August 22, 2011]. Vaccine.
11. Healthy People 2020. US Department of Health and Human Services. Office of Disease Prevention and Health Promotion. http://www.healthypeople.gov/2020/ default.aspx. Accessed May 30, 2012.
12. Steyer TE, Ragucci KR, Pearson WS, Mainous AG 3rd. The role of pharmacists in the delivery of influenza vaccinations. Vaccine. 2004; 22(8):1001-1006.
13. Prosser LA, O'Brien MA, Molinari NA, et al. Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness. Pharmaco Economics. 2008;26(2):163-178.